112 related articles for article (PubMed ID: 7549115)
21. [Chemotherapy for older cancer patients].
Urushizaki I
Gan To Kagaku Ryoho; 1993 May; 20(7):850-7. PubMed ID: 7683866
[TBL] [Abstract][Full Text] [Related]
22. Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors.
Tranchand B; Catimel G; Lucas C; Sarkany M; Bastian G; Evene E; Guastalla JP; Négrier S; Rebattu P; Dumortier A; Foy M; Grossin F; Mazier B; Froudarakis M; Barbet N; Clavel M; Ardiet C
Cancer Chemother Pharmacol; 1998; 41(4):281-91. PubMed ID: 9488597
[TBL] [Abstract][Full Text] [Related]
23. Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.
Wong CM; Rabl A; Thach TQ; Chau YK; Chan KP; Cowling BJ; Lai HK; Lam TH; McGhee SM; Anderson HR; Hedley AJ
Res Rep Health Eff Inst; 2012 Aug; (170):5-91. PubMed ID: 23316618
[TBL] [Abstract][Full Text] [Related]
24. Cancer, clinical pharmacology, and aging.
Hutchins LF; Lipschitz DA
Clin Geriatr Med; 1987 Aug; 3(3):483-503. PubMed ID: 3308046
[TBL] [Abstract][Full Text] [Related]
25. Non-Hodgkin's lymphoma in the elderly.
Caimi PF; Barr PM; Berger NA; Lazarus HM
Drugs Aging; 2010 Mar; 27(3):211-38. PubMed ID: 20210368
[TBL] [Abstract][Full Text] [Related]
26. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
27. Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer.
Vergati M; Della-Morte D; Ferroni P; Cereda V; Tosetto L; La Farina F; Guadagni F; Roselli M
Rejuvenation Res; 2013 Jun; 16(3):224-31. PubMed ID: 23521603
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
29. Greater risks of chemotherapy toxicity in elderly patients with cancer.
Repetto L
J Support Oncol; 2003; 1(4 Suppl 2):18-24. PubMed ID: 15346996
[TBL] [Abstract][Full Text] [Related]
30. Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction.
Ambrose PG; Bhavnani SM; Cirincione BB; Piedmonte M; Grasela TH
J Antimicrob Chemother; 2003 Sep; 52(3):435-40. PubMed ID: 12917247
[TBL] [Abstract][Full Text] [Related]
31. Minimising the side effects of cancer chemotherapy in senior patients.
Kinzel T; Feleppa V
Drugs Aging; 1992; 2(2):137-45. PubMed ID: 1596596
[TBL] [Abstract][Full Text] [Related]
32. Cancer chemotherapy in the elderly patient.
McCardell M; Chase JL
Dimens Oncol Nurs; 1990; 4(2):16-23. PubMed ID: 2206360
[TBL] [Abstract][Full Text] [Related]
33. Aging and cancer.
Misra D; Seo PH; Cohen HJ
Clin Adv Hematol Oncol; 2004 Jul; 2(7):457-65. PubMed ID: 16163222
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy-induced emesis in elderly cancer patients: the role of 5-HT3-receptor antagonists in the first 24 hours.
Aapro M; Johnson J
Gerontology; 2005; 51(5):287-96. PubMed ID: 16110229
[TBL] [Abstract][Full Text] [Related]
35. Aging, frailty, and chemotherapy.
Balducci L
Cancer Control; 2007 Jan; 14(1):7-12. PubMed ID: 17242666
[TBL] [Abstract][Full Text] [Related]
36. Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer.
Jodrell DI; Reyno LM; Sridhara R; Eisenberger MA; Tkaczuk KH; Zuhowski EG; Sinibaldi VJ; Novak MJ; Egorin MJ
J Clin Oncol; 1994 Jan; 12(1):166-75. PubMed ID: 8270974
[TBL] [Abstract][Full Text] [Related]
37. Cancer chemotherapy in the elderly.
Conti JA; Christman K
J Clin Gastroenterol; 1995 Jul; 21(1):65-71. PubMed ID: 7560837
[TBL] [Abstract][Full Text] [Related]
38. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
Rusthoven J; Bramwell V; Stephenson B
Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
[TBL] [Abstract][Full Text] [Related]
39. Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomes.
Desch CE; Hillner BE; Smith TJ; Retchin SM
J Clin Oncol; 1993 Apr; 11(4):777-82. PubMed ID: 8478671
[TBL] [Abstract][Full Text] [Related]
40. [Contribution of computers to pharmacokinetics, Bayesian approach and population pharmacokinetics].
Hecquet B
Bull Cancer; 1995 Dec; 82 Suppl 5():607s-611s. PubMed ID: 8680074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
